Research conducted by a local hospital has found that hepatitis B patients with a simple fatty liver have a lower mortality ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

In Europe, the introduction of HBV vaccination has markedly reduced the incidence of acute HBV ... [1] Since 1992, the inclusion of hepatitis B vaccination has been recommended by the WHO in ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Viral infections such as hepatitis A and E cause acute hepatitis, whereas Hepatitis B and C cause chronic infections. Other viral infections, such as dengue, Herpes simplex etc, also can cause ...

Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for long-term management. This study aimed to evaluate the real-world ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all ...